While the case in Bali has shocked travelers to the region, this is not the first time tourist deaths have been blamed on bed ...
The trip of a lifetime to the paradise island of Bali turned deadly for a 25-year-old Chinese tourist who died while staying ...
November 20, 2025Evogene Ltd. beats earnings expectations. Reported EPS is $-0.31, expectations were $-0.41. Operator: ...
Q3 2025 Earnings Call November 20, 2025 9:00 AM ESTCompany ParticipantsOfer Haviv - CEO, President & DirectorYaron Eldad - ...
A new word is making the rounds in the business press: "anti-involution." In recent years, Chinese companies have built ...
The pharma company said asundexian, when combined with antiplatelet therapy, lowered the risk of stroke in patients during ...
The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
Bayer (BAYZF) stock is in focus as the FDA grants accelerated approval for the company's tumor drug Hyrnuo in non-squamous ...
Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...
The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...
The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 ...
Bayer has joined its peers among European drugmakers with a hike in pharma forecasts for the year, as it recorded a rise in group sales, but lower profits for the second quarter. Total revenues came ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results